Revenue
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Charles River Laboratories International, Inc. (CRL)
Price$292.84Cached quote
Net income
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.02B | $4.05B | $4.13B | $3.98B | $3.54B | $2.92B | $2.62B | $2.27B | $1.86B | $1.68B | $1.36B | $1.30B | $1.17B | $1.13B | $1.14B | $1.13B | $1.17B | $1.30B |
| Gross profit | $1.32B | $1.33B | $1.50B | $1.46B | — | — | — | — | $1.57B | $1.40B | $1.10B | $1.03B | $892.8M | $871.8M | $874.7M | $880.5M | $916.0M | $1.04B |
| Gross margin | 32.96% | 32.88% | 36.39% | 36.79% | — | — | — | — | 84.41% | 83.52% | 80.64% | 79.47% | 76.60% | 77.18% | 76.55% | 77.68% | 78.18% | 80.47% |
| Operating expenses | $922.1M | $889.5M | $885.3M | $811.7M | — | — | — | — | $1.28B | $1.17B | $892.9M | $853.6M | $741.4M | $706.1M | $700.4M | $1.18B | $746.3M | $1.49B |
| Operating income | $25.2M | $227.3M | $617.3M | $651.0M | $589.9M | $432.7M | $351.2M | $331.4M | $288.3M | $237.6M | $206.4M | $177.7M | $151.4M | $165.8M | $174.3M | −$298.5M | $169.6M | −$451.8M |
| Operating margin | 0.63% | 5.61% | 14.95% | 16.37% | 16.66% | 14.80% | 13.40% | 14.62% | 15.52% | 14.13% | 15.14% | 13.69% | 12.99% | 14.68% | 15.25% | −26.34% | 14.48% | −34.88% |
| EBITDA | $428.5M | $589.1M | $931.4M | $954.8M | $855.4M | $667.7M | $549.2M | $493.2M | $419.4M | $364.2M | $301.3M | $274.1M | $248.0M | $247.0M | $259.5M | −$204.9M | $259.6M | −$365.0M |
| EBITDA margin | 10.67% | 14.55% | 22.55% | 24.01% | 24.16% | 22.83% | 20.95% | 21.76% | 22.58% | 21.66% | 22.10% | 21.12% | 21.28% | 21.87% | 22.71% | −18.07% | 22.15% | −28.18% |
| Net income | −$144.3M | $22.2M | $474.6M | $486.2M | $391.0M | $364.3M | $252.0M | $226.4M | $123.4M | $154.8M | $149.3M | $126.7M | $102.8M | $97.9M | $110.0M | −$336.7M | $114.4M | −$524.5M |
| Net profit margin | −3.59% | 0.55% | 11.49% | 12.23% | 11.04% | 12.46% | 9.61% | 9.99% | 6.64% | 9.20% | 10.95% | 9.76% | 8.82% | 8.66% | 9.62% | −29.70% | 9.77% | −40.49% |
| Basic EPSper basic share | -$2.91 | $0.20 | $9.27 | $9.57 | $7.77 | $7.35 | $5.17 | $4.72 | $2.60 | $3.29 | $3.21 | $2.72 | $2.15 | $2.03 | $2.16 | -$5.38 | $1.75 | -$7.80 |
| Diluted EPSper diluted share | -$2.91 | $0.20 | $9.22 | $9.48 | $7.60 | $7.20 | $5.07 | $4.62 | $2.54 | $3.23 | $3.13 | $2.66 | $2.12 | $2.01 | $2.14 | -$5.38 | $1.74 | -$7.80 |
Owners
Reported shareholders
≈8.88%of listed shares
FMR LLC4.24M shares · Jun 30, 2026
View holders
| Holder | % owned |
|---|---|
FMR LLC | ≈8.88%4.24M shares |
BlackRock, Inc. | ≈7.96%3.8M shares |
VANGUARD CAPITAL MANAGEMENT LLC | ≈6.60%3.15M shares |
Invesco Ltd. | ≈6.25%2.98M shares |
HARRIS ASSOCIATES L P | ≈4.70%2.24M shares |
VANGUARD PORTFOLIO MANAGEMENT LLC | ≈4.63%2.21M shares |
Allspring Global Investments Holdings, LLC | ≈3.99%1.91M shares |
STATE STREET CORP | ≈3.91%1.86M shares |
DIMENSIONAL FUND ADVISORS LP | ≈3.45%1.65M shares |
ARIEL INVESTMENTS, LLC | ≈3.16%1.51M shares |
PRICE T ROWE ASSOCIATES INC /MD/ | ≈3.15%1.51M shares |
GEODE CAPITAL MANAGEMENT, LLC | ≈2.74%1.31M shares |
WELLINGTON MANAGEMENT GROUP LLP | ≈2.70%1.29M shares |
CITADEL ADVISORS LLC | ≈2.50%1.19M shares |
BANK OF AMERICA CORP /DE/ | ≈2.46%1.17M shares |
EARNEST PARTNERS LLC | ≈2.35%1.12M shares |
AMERIPRISE FINANCIAL INC | ≈1.85%881.19K shares |
NEUBERGER BERMAN GROUP LLC | ≈1.81%862.7K shares |
SEI INVESTMENTS CO | ≈1.70%813.53K shares |
MORGAN STANLEY | ≈1.68%800.49K shares |
Percentages use 47.73M shares of this listed class outstanding on Jun 27, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Mar 3, 2026Form 4 | LaPlume Joseph WEVP, Corp Strategy & Develop | BuyCommon Stock | 25 | $174.54 | $4.4K | 27.4K |
| Aug 22, 2025Form 4 | LaPlume Joseph WEVP, Corp Strategy & Develop | SellCommon Stock | 400 | $163.72 | $65.5K | 23.7K |
| Aug 18, 2025Form 4 | LaPlume Joseph WEVP, Corp Strategy & Develop | SellCommon Stock | 800 | $157.60 | $126.1K | 24.1K |
| Aug 7, 2025Form 4 | LaPlume Joseph WEVP, Corp Strategy & Develop | SellCommon Stock | 400 | $150.04 | $60.0K | 24.9K |
| May 15, 2025Form 4 · 10b5-1 | MASSARO GEORGEDirector | SellCommon Stock | 24 | $139.05 | $3.3K | 5.6K |